
BHVN
Marshall Wace’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-19,406
| Closed | -$2.93M | – | 3653 |
|
2022
Q3 | $2.93M | Sell |
19,406
-1,909,218
| -99% | -$289M | 0.01% | 1414 |
|
2022
Q2 | $281M | Sell |
1,928,624
-472,660
| -20% | -$68.9M | 0.58% | 18 |
|
2022
Q1 | $285M | Sell |
2,401,284
-397,173
| -14% | -$47.1M | 0.54% | 20 |
|
2021
Q4 | $386M | Buy |
2,798,457
+80,272
| +3% | +$11.1M | 0.71% | 16 |
|
2021
Q3 | $378M | Sell |
2,718,185
-14,183
| -0.5% | -$1.97M | 1.57% | 1 |
|
2021
Q2 | $265M | Sell |
2,732,368
-44,099
| -2% | -$4.28M | 1.2% | 5 |
|
2021
Q1 | $190M | Buy |
2,776,467
+219,915
| +9% | +$15M | 0.87% | 9 |
|
2020
Q4 | $219M | Buy |
2,556,552
+28,702
| +1% | +$2.46M | 1.19% | 8 |
|
2020
Q3 | $164M | Buy |
2,527,850
+26,406
| +1% | +$1.72M | 1.05% | 11 |
|
2020
Q2 | $183M | Sell |
2,501,444
-61,999
| -2% | -$4.53M | 1.28% | 6 |
|
2020
Q1 | $87.2M | Buy |
2,563,443
+2,312,881
| +923% | +$78.7M | 0.87% | 17 |
|
2019
Q4 | $13.6M | Sell |
250,562
-287,235
| -53% | -$15.6M | 0.09% | 221 |
|
2019
Q3 | $22.4M | Buy |
537,797
+251,836
| +88% | +$10.5M | 0.18% | 121 |
|
2019
Q2 | $12.5M | Buy |
285,961
+278,863
| +3,929% | +$12.2M | 0.1% | 215 |
|
2019
Q1 | $365K | Buy |
+7,098
| New | +$365K | ﹤0.01% | 1214 |
|